Insider Stock Trading History of Mollica Joseph A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mollica Joseph A since year 2005. The trader's CIK number is 1126489. At the time of this reporting, Mollica Joseph A is the Director of Neurocrine Biosciences Inc . (stock ticker symbol NBIX). See this page for all insider trading activities at Neurocrine Biosciences Inc .

Note that in the past MOLLICA JOSEPH A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Mollica Joseph A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-04-12 NBIX Neurocrine Biosciences Inc Option Ex 20,000 3.40 68,000
2016-02-10 NBIX Neurocrine Biosciences Inc Option Ex 20,000 3.07 61,400
2014-12-12 NBIX Neurocrine Biosciences Inc Option Ex 20,000 4.76 95,200
2014-04-16 NBIX Neurocrine Biosciences Inc Option Ex 15,000 12.37 185,550
2013-03-28 NBIX Neurocrine Biosciences Inc Option Ex 15,000 10.60 159,000
2007-09-10 PCOP Pharmacopeia Drug Discovery Inc Sale 8,399 5.60 47,034
2007-09-10 PCOP Pharmacopeia Drug Discovery Inc Option Ex 8,399 2.82 23,701
2007-09-06 PCOP Pharmacopeia Drug Discovery Inc Sale 5,000 5.73 28,650
2007-09-06 PCOP Pharmacopeia Drug Discovery Inc Option Ex 5,000 2.82 14,110
2007-09-04 PCOP Pharmacopeia Drug Discovery Inc Option Ex 5,000 2.82 14,110
2007-09-05 PCOP Pharmacopeia Drug Discovery Inc Option Ex 10,000 2.82 28,220
2007-09-04 PCOP Pharmacopeia Drug Discovery Inc Sale 5,000 5.62 28,115
2007-09-05 PCOP Pharmacopeia Drug Discovery Inc Sale 10,000 5.60 56,000
2007-08-30 PCOP Pharmacopeia Drug Discovery Inc Option Ex 100 2.82 282
2007-08-30 PCOP Pharmacopeia Drug Discovery Inc Sale 100 5.65 565
2007-08-29 PCOP Pharmacopeia Drug Discovery Inc Option Ex 500 2.82 1,411
2007-08-29 PCOP Pharmacopeia Drug Discovery Inc Sale 500 5.55 2,775
2007-08-27 PCOP Pharmacopeia Drug Discovery Inc Option Ex 10,000 2.82 28,220
2007-08-27 PCOP Pharmacopeia Drug Discovery Inc Sale 10,000 5.54 55,439
2007-03-15 PCOP Pharmacopeia Drug Discovery Inc Option Ex 10,000 2.82 28,220
2007-03-15 PCOP Pharmacopeia Drug Discovery Inc Sale 10,000 5.26 52,600
2007-03-14 PCOP Pharmacopeia Drug Discovery Inc Option Ex 10,000 2.82 28,220
2007-03-14 PCOP Pharmacopeia Drug Discovery Inc Sale 10,000 5.08 50,810
2007-03-13 PCOP Pharmacopeia Drug Discovery Inc Sale 10,000 5.14 51,400
2007-03-12 PCOP Pharmacopeia Drug Discovery Inc Sale 10,000 5.24 52,400
2007-03-13 PCOP Pharmacopeia Drug Discovery Inc Option Ex 10,000 2.82 28,220
2007-03-12 PCOP Pharmacopeia Drug Discovery Inc Option Ex 10,000 2.82 28,220
2007-03-09 PCOP Pharmacopeia Drug Discovery Inc Option Ex 5,000 2.82 14,110
2007-03-09 PCOP Pharmacopeia Drug Discovery Inc Sale 5,000 5.30 26,500
2007-03-07 PCOP Pharmacopeia Drug Discovery Inc Option Ex 5,000 2.82 14,110
2007-03-08 PCOP Pharmacopeia Drug Discovery Inc Option Ex 10,000 2.82 28,220
2007-03-07 PCOP Pharmacopeia Drug Discovery Inc Sale 5,000 4.72 23,585
2007-03-08 PCOP Pharmacopeia Drug Discovery Inc Sale 10,000 4.83 48,339

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mollica Joseph A (Director of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.